4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-045921
Director sold 9,000 shares at an average $56.36 ($507,260)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cantley Lewis Clayton Jr. Director | 2017-07-19 | Sale | −3,000 | $56.15 | $168,450 | 86,697 | D |
| Cantley Lewis Clayton Jr. Director | 2017-07-19 | Sale | −3,000 | $56.15 | $168,450 | 86,737 | I |
| Cantley Lewis Clayton Jr. Director | 2017-07-19 | Sale | −500 | $56.11 | $28,055 | 86,197 | D |
| Cantley Lewis Clayton Jr. Director | 2017-07-19 | Sale | −500 | $56.11 | $28,055 | 86,237 | I |
| Cantley Lewis Clayton Jr. Director | 2017-07-20 | Sale | −500 | $57.12 | $28,560 | 85,697 | D |
| Cantley Lewis Clayton Jr. Director | 2017-07-20 | Sale | −500 | $57.12 | $28,560 | 85,737 | I |
| Cantley Lewis Clayton Jr. Director | 2017-07-20 | Sale | −500 | $57.13 | $28,565 | 85,197 | D |
| Cantley Lewis Clayton Jr. Director | 2017-07-20 | Sale | −500 | $57.13 | $28,565 | 85,237 | I |
| Open-market sales · 9,000 sh · avg $56.36 · $507,260 | |||||||
Loading xslF345X03/doc4.xml…